Habitual sleep patterns and risk for stroke and coronary heart disease

Qureshi, Adnan I; Giles, Wayne H.; Croft, Janet B.; Bliwise, Donald L.

doi:10.1212/wnl.48.4.904

Cited by 304 publications

(270 citation statements)

References 0 publications

Supporting

Mentioning

244

Contrasting

Unclassified

Order By: Relevance

“…A total of 74 studies met the inclusion criteria; the process of study selection is shown in Figure 1 8, 9, 11, 12, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89,...…”

Section: Resultsmentioning

confidence: 99%

“…Linear spline analysis for stroke mortality and stroke included 347, 49, 65 and 98, 22, 31, 42, 43, 50, 69, 76, 83 studies, respectively. There was no difference in stroke events associated with self‐reported sleep duration shorter or longer than 7 hours, but a moderate increase in stroke mortality if sleep duration was >7 hours (Figure 3, Data S8).…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Self‐Reported Sleep Duration and Quality and Cardiovascular Disease and Mortality: A Dose‐Response Meta‐Analysis

Kwok

Kontopantelis

Kuligowski

et al. 2018

JAHA

276

184

View full text Add to dashboard Cite

BackgroundThere is growing evidence that sleep duration and quality may be associated with cardiovascular harm and mortality.Methods and ResultsWe conducted a systematic review, meta‐analysis, and spline analysis of prospective cohort studies that evaluate the association between sleep duration and quality and cardiovascular outcomes. We searched MEDLINE and EMBASE for these studies and extracted data from identified studies. We utilized linear and nonlinear dose‐response meta‐analysis models and used DerSimonian–Laird random‐effects meta‐analysis models of risk ratios, with inverse variance weighting, and the I2 statistic to quantify heterogeneity. Seventy‐four studies including 3 340 684 participants with 242 240 deaths among 2 564 029 participants who reported death events were reviewed. Findings were broadly similar across both linear and nonlinear dose‐response models in 30 studies with >1 000 000 participants, and we report results from the linear model. Self‐reported duration of sleep >8 hours was associated with a moderate increased risk of all‐cause mortality, with risk ratio, 1.14 (1.05–1.25) for 9 hours, risk ratio, 1.30 (1.19–1.42) for 10 hours, and risk ratio, 1.47 (1.33–1.64) for 11 hours. No significant difference was identified for periods of self‐reported sleep <7 hours, whereas similar patterns were observed for stroke and cardiovascular disease mortality. Subjective poor sleep quality was associated with coronary heart disease (risk ratio, 1.44; 95% confidence interval, 1.09–1.90), but no difference in mortality and other outcomes.ConclusionsDivergence from the recommended 7 to 8 hours of sleep is associated with a higher risk of mortality and cardiovascular events. Longer duration of sleep may be more associated with adverse outcomes compared with shorter sleep durations.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Self‐Reported Sleep Duration and Quality and Cardiovascular Disease and Mortality: A Dose‐Response Meta‐Analysis

Kwok

Kontopantelis

Kuligowski

et al. 2018

JAHA

276

184

View full text Add to dashboard Cite

show abstract

“…In the analysis of the pooled OR for long sleep and MetS (Figure 4), we identified two studies (30,33) as outliers. The study by Najafian and colleagues (30), with a total of 12,492 individuals, and that of Sabanayagam and colleagues (33), with a data of 10 SYSTEMATIC REVIEW significant weight on the overall analysis. The study by Najafian and colleagues (30) concluded that long sleep (.9 h) had a "protective" effect (OR, 0.79; 95% CI, 0.68-0.94).…”

Section: Systematic Reviewmentioning

confidence: 99%

“…Habitual short sleep duration is also associated with a host of chronic health conditions such as hypertension, diabetes, depression, obesity, certain cancers, and increased mortality (4)(5)(6)(7)(8)(9). On the other hand, long sleep duration has also been associated with chronic health problems such as obesity, diabetes, heart disease, and stroke (10)(11)(12)(13)(14)(15)(16). In fact, in several studies, the association between long sleep duration and health problems is even stronger than that found with short sleep duration (12,17,18).…”

mentioning

confidence: 99%

Sleep Duration and Metabolic Syndrome. An Updated Dose–Risk Metaanalysis

et al. 2015

View full text Add to dashboard Cite

Rationale: Several studies have reported that both short and long sleep durations are associated with the metabolic syndrome, but whether a dose-response relationship exists is unclear.Objectives: We performed a metaanalysis to study the magnitude of the association between the different durations of sleep and metabolic syndrome. Methods:We searched in the databases of PubMed, Web of Science, and Ovid (all Journals@Ovid) from inception to October 4, 2014 for cross-sectional studies where an association between metabolic syndrome and sleep duration was analyzed. Measurements and Main Results:Eighteen studies with 75,657 participants were included. Daily sleep duration of 7 to 8 hours was used as the reference group. The odds ratio (OR) of having metabolic syndrome for short (,7 h) sleep was 1.23 (95% CI, 1.11-1.37; P , 0.001; I 2 , 71%). The ORs for less than 5 hours, 5 to 6 hours, and 6 to 7 hours of sleep were 1.51 (95% CI, 1.10-2.08; P = 0.01), 1.28 (95% CI, 1.11-1.48; P , 0.001), and 1.16 (95% CI, 1.02-1.31; P = 0.02), respectively. The coefficient of sleep duration on log of ORs was 20.06 6 0.02 (P = 0.02). The OR for long sleep duration was 1.13 (95% CI, 0.97-1.32; P = 0.10; I 2 , 89%).Conclusions: A dose-response relationship exists between short sleep duration and metabolic syndrome. Those who report a sleep duration of less than 5 hours have a 1.5 higher odds of having metabolic syndrome. Our study does not support the notion that long sleep is associated with metabolic syndrome.

show abstract

“…Başka çalışmalar, gün içi aşırı uykululuk hali, uzamış uyku süresi, yorgunluk gibi SUB semptomlarının da SVO için birer risk faktörü olabileceğini ortaya koymuştur (2). unutulmamalıdır (14).…”

Section: Horlamakunclassified

Sleep related breathing disorders and cerebrovascular diseases

Erdinç¹

2010

Türk Beyin Damar Hast Derg

View full text Add to dashboard Cite

ÖZETObstrüktif uyku apne sendromu (OSAS), yüksek prevalanslı ve sıklıkla gözden kaçan, solunumla ilişkili bir uyku bozukluğudur. Uykuda üst hava yollarının gevşeyerek hava yolunu tıkaması sonucu oluşur. Gece boyunca sık uyanmalar, hipoksemi, uykunun bölünmesi ve uyku kalitesinin düşmesi ile izlenir. Şiddetli horlama, tanıklı apneler ve gün içi aşırı uykululuk durumu en önemli semptomlardır. Artmış sempatik aktivite, metabolik ve inflamatuvar markerlar, OSAS ve serebrovasküler hastalıklar arasındaki olası ortak mekanizmayı açıklayabilir. Tedavi seçenekleri için bu mekanizmaların çok iyi bilinmesi gerekir. OSAS'ın erken tanısı ve tedavisi bireyleri serebrovasküler ve diğer komplikasyonlardan koruyabilecektir. SLEEP RELATED BREATHING DISORDERS AND CEREBROVASCULAR DISEASES ABSTRACTObstructive sleep apnea (OSA) is a form of sleep disordered breathing, with a high prevalence rate and is often underdiagnosed. It is characterized by frequent episodes of upper airway collapse during sleep, causing recurrent arousals, intermittent hypoxaemia, sleep fragmentation and poor sleep quality. The common clinical symptoms are heavy snoring, witnessed apnea and daytime hypersomnolence, which would help to identify the affected individuals. Increased sympathetic drive, activation of metabolic and inflammatory markers, and impaired vascular function are some of the proposed mechanisms that could explain the association between OSA and cerebrovascular diseases. Understanding these mechanisms is important for identifying treatment strategies. Increased sympathetic drive, activation of metabolic and inflammatory markers, and impaired vascular function are some of the proposed mechanisms that could explain the association between OSA and cardiovascular diseases. Early recognition and treatment of obstructive sleep apnoea may prevent from adverse health consequences.Yazışma Adresi: Oğuz Osman ERDİNÇ Eskişehir Osmangazi Üniversitesi Tıp Fakültesi Nöroloji Anabilim Dalı, ESKİŞEHİR 1 DERLEME REVIEW Epidemiyoloji OSAS'ın prevalans değerleri kadınlarda %9, erkeklerde %24 şeklinde bildirilmiştir (3). SVO da aynı şekilde sık rastlanılan bir tablodur ve ABD'de üçüncü sıklıkta gelen ölüm nedeni olarak bilinmektedir. Olgu sayısı yılda 700.000'e ulaşmış ve akut nörolojik yakınmalarla başvuran olguların yarısını oluşturmuştur (4). Dünyada ele alındığında, SVO ikinci majör ölüm veya uzun süreli maluliyet nedenidir (5). Obstrüktif apne hipopne indeksine (AHI) göre hafif ve orta şiddetteki OSAS'ın varlığı bile, hastaların SVO için önleyici tedavi almaları gerektiğini göstermektedir (6). HorlamakHorlamak, OSAS'ın en önemli belirtecidir (7). Sık horlama faktörü aynı zamanda, hipertansiyon, kalp hastalıkları, demans ve SVO için oldukça önemlidir (8).Horlamak orta yaşlı erkeklerde ortalama %40-45, aynı yaş grupta kadınlarda %25-30 sıklığındadır. Uykuda meydana gelen SVO olguları horlama ile Solunum ile ilişkili uyku bozuklukları (SUB) içinde en sık rastlanılanı obstrüktif uyku apne sendromudur (OSAS). Klinik semptomlar çok iyi bilinmez veya tanımlanmaz ise...

show abstract

Habitual sleep patterns and risk for stroke and coronary heart disease

Abstract: Habitual sleep patterns have significant effects on the risk for stroke.

Cited by 304 publications

References 0 publications

Self‐Reported Sleep Duration and Quality and Cardiovascular Disease and Mortality: A Dose‐Response Meta‐Analysis

Self‐Reported Sleep Duration and Quality and Cardiovascular Disease and Mortality: A Dose‐Response Meta‐Analysis

Sleep Duration and Metabolic Syndrome. An Updated Dose–Risk Metaanalysis

Sleep related breathing disorders and cerebrovascular diseases

Contact Info

Product

Resources

About